Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naftopidil with or without trospium chloride for intramural ureteral stone
ChiCTR-IPR-15006185Phase 4Recruiting
- Sponsor
- Nanjing Medical University Affiliated Nanjing Hospital
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ureterolithiasis comparing Naftopidil + trospium placebo, Naftopidil + trospium chloride and Trospium chloride (3 arms). Primary endpoint: Pain scores. Started Mar 2015; status: recruiting.
02
Drugs
naftopidiltrospium
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on ChiCTR-IPR-15006185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006185.